omega-n-methylarginine has been researched along with palmitic acid in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (palmitic acid) | Trials (palmitic acid) | Recent Studies (post-2010) (palmitic acid) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 6,794 | 159 | 2,458 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | palmitic acid (IC50) |
---|---|---|---|
Toll-like receptor 2 | Homo sapiens (human) | 5 | |
Fatty acid-binding protein, intestinal | Homo sapiens (human) | 1.7 | |
Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 0.93 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.8 | |
Fatty acid-binding protein 5 | Homo sapiens (human) | 1.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lundman, P; Nilsson, L; Pernow, J; Tornvall, P | 1 |
Halliwill, JR; Jensen, MD; Joyner, MJ; Nielsen, S | 1 |
2 other study(ies) available for omega-n-methylarginine and palmitic acid
Article | Year |
---|---|
A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation.
Topics: Acetylcholine; Animals; Antioxidants; Ascorbic Acid; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Femoral Artery; In Vitro Techniques; Lipoproteins, VLDL; Male; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Oleic Acid; omega-N-Methylarginine; Palmitic Acid; Penicillamine; Rats; Rats, Sprague-Dawley; Triglycerides; Vasodilation; Vasodilator Agents | 2001 |
Vascular response to angiotensin II in upper body obesity.
Topics: Acetylcholine; Adult; Angiotensin II; Blood Glucose; Body Composition; Dose-Response Relationship, Drug; Forearm; Humans; Hypertension; Insulin Resistance; Lipolysis; Male; Nitric Oxide Synthase; Nitroprusside; Obesity; omega-N-Methylarginine; Palmitic Acid; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |